ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

CINGW Cingulate Inc

0,0218
0,0002 (0,93%)
Zuletzt aktualisiert: 18:28:33
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cingulate Inc CINGW NASDAQ Equity Warrant
  Änderung Änderung % Aktuell Zeit
0,0002 0,93% 0,0218 18:28:33
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,0218 0,0218 0,0218 0,0216
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.5.202413:10EDGAR2Form 8-K - Current report
08.5.202413:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30.4.202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16.4.202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01.4.202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19.3.202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
06.3.202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13.2.202412:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
06.2.202422:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
02.2.202415:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29.1.202414:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29.1.202412:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
01.12.202315:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
13.11.202322:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
17.10.202320:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
21.9.202319:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
13.9.202322:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11.9.202315:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11.9.202312:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
08.9.202322:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05.9.202314:00GLOBECingulate Announces Presentation of Full Trial Results from..
14.8.202322:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11.7.202314:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29.6.202314:00GLOBECingulate Successfully Manufactures Clinical Supply –..
14.6.202321:45GLOBECingulate to Participate in the Healthcare Virtual..
08.6.202313:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..
25.5.202321:55GLOBECingulate to Present at 13th Annual LD Micro Invitational
12.5.202321:45GLOBECingulate, Indegene to Participate in Benzinga All Live..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock